Type 2 Diabetes Reversal: Rajesh K. (Mumbai, 58) — HbA1c 9.2 → 5.8 in 4 Months

UrCare Doctor Team @ May 01, 2026

Rajesh K., 58, Type 2 diabetes reversal patient from Mumbai

Patient profile

Name: Rajesh K.
Age: 58 · Sex: Male
City: Mumbai, India
Diagnosis: Type 2 Diabetes Mellitus (8 years duration)
Co-morbidities at intake: mild hypertension, central adiposity

Starting numbers

HbA1c: 9.2%
Fasting glucose: 178 mg/dL
Medications: Metformin 1g BID + Glimepiride 2mg + statin

Personalised protocol

The UrCare doctor team prescribed a hyper-personalised reversal kit combining PancreReViv (beta-cell support) and GlucoLow (insulin-sensitivity), a low-glycaemic Indian meal plan tuned to Rajesh's regional preferences (millet rotis, dal-vegetable plates, controlled rice portions), a structured 30-minute post-meal walk routine, and weekly tele-consults with his case doctor.

Timeline

Week 2: Fasting glucose under 130 mg/dL — Glimepiride dropped.
Month 2: HbA1c re-test 7.1% — weight down 4.6 kg.
Month 4: HbA1c 5.8% — Metformin reduced by 80%; statin under review.

Outcome

HbA1c moved from 9.2% to 5.8% in 4 months, achieving remission as defined by the ADA (HbA1c < 6.5% sustained off glucose-lowering therapy). Medication burden cut by 80%. Energy, sleep and BP all reported improved.

In Rajesh's words

"HbA1c from 9.2 to 5.8 in 4 months. Reduced medication by 80%. The weekly check-ins kept me on track — I feel ten years younger."

This case is part of UrCare's documented Type 2 reversal cohort. Outcomes vary by individual baseline, adherence and co-morbidities. Always consult your doctor before changing medication.